搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
Cancer Therapy Advisor
18 小时
How Billing for Patient Portal Messages Impacts Patients, Physicians
The policy of billing for patient portal messages changes patient expectations and can impact the patient-physician ...
Cancer Therapy Advisor
17 小时
Study Reveals “Substantial” Population of AYA Cancer Survivors in the US
An analysis of AYA cancer survivors in the US revealed “a substantial population of aging, long-term cancer survivors,” according to researchers.
Cancer Therapy Advisor
18 小时
Vyloy Approved for Gastric, GEJ Cancer
The FDA has approved Vyloy (zolbetuximab-clzb) in combination with chemotherapy to treat advanced gastric or GEJ cancer.
Cancer Therapy Advisor
3 天
AI-Generated Patient Portal Messages Get Mixed Reviews
Nurses were more likely than other health care workers to favor using AI-generated responses to patient portal messages.
Cancer Therapy Advisor
4 天
Psilocybin-Assisted Psychotherapy Can Improve Psychiatric Symptoms in Cancer Patients
Psilocybin-assisted psychotherapy “has the potential to be a comprehensive mental health treatment for patients with cancer,” ...
Cancer Therapy Advisor
3 天
Radon Exposure Tied to Higher Risk for Childhood Leukemia
Exposure to radon levels, even below current recommended levels, heightens the risk for childhood leukemia, a study suggests.
Cancer Therapy Advisor
6 天
Thoracic Radiotherapy Improves Upon Icotinib in Oligometastatic NSCLC
Patients with EGFR-mutant, oligometastatic NSCLC who received radiotherapy plus icotinib had longer overall and ...
Cancer Therapy Advisor
12 天
Farah Yousry, Side Effects Public Media
Baxter International, the largest maker of IV fluids in the US, said its manufacturing plant in North Carolina, which ...
Cancer Therapy Advisor
4 天
Data Support Induction Chemo as Standard Care for Locally Advanced Cervical Cancer
Short-course induction chemotherapy prior to chemoradiotherapy should be considered a standard of care, according to ...
Cancer Therapy Advisor
5 天
OS Is Similar for Patients With Hematologic Malignancies Diagnosed During Pregnancy and After
The 5-year overall survival rate was 91.2% in patients diagnosed with hematologic malignancies during pregnancy and 90.3% in ...
Cancer Therapy Advisor
6 天
Trastuzumab Biosimilars as Safe as Originator in HER2+ Breast Cancer
Researchers found “no significant discrepancy in safety events” between trastuzumab biosimilars and the originator product.
Cancer Therapy Advisor
4 天
Nivolumab Bests Brentuximab Vedotin in Advanced Hodgkin Lymphoma
Nivolumab plus AVD “should be a strong candidate for primary treatment in adolescent and adult patients with stage III or IV Hodgkin’s lymphoma,” according to researchers.
当前正在显示可能无法访问的结果。
隐藏无法访问的结果
反馈